VEGFA and macular retinal edema: While the use of anti-VEGF therapy in ocular toxocariasis is still under exploration, it appears to be a promising adjunct treatment, particularly for managing macular edema, vascular leakage, and neovascularization resulting from the chronic inflammatory response associated with the infection.